Ethnicity affects the presenting severity of psoriasis
To the Editor: Psoriasis is a chronic inflammatory condition that occurs worldwide; however, data on the clinical features of psoriasis in racial minorities are scarce. 1 Recent population-based studies in the United States have observed a prevalence of 3.6% in whites, 1.9% in African Americans, and 1.6% in Hispanics. 2 However, there have been few studies specifically looking at the severity of psoriasis in different ethnicities. Some studies have been published on the clinical variation of psoriasis in skin of color, specifically African Americans who may present with a different set of defining characteristics. 3 These patients may present with less conspicuous erythema that may appear violaceous or hyperpigmented, making it harder to appreciate areas of active inflammation compared to lighter skin. 4 In addition, Asians have been reported to have greater body surface area involvement at initial presentation compared to whites. 5 The purpose of this cross-sectional study was to determine whether there are any differences in the presenting severity of psoriasis based on ethnicity. We examined a database of psoriasis patients seen at the University of California, San Francisco Department of Dermatology (Table I ). The database included 848 patients with psoriasis between 2006 and 2016, with 62% self-identified as white, 26% Asian, 8% Hispanic, 2% African American, and 2% 
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Middle Eastern. This database was analyzed using the analysis of covariance regression model to determine whether there was a statistically significant difference in the presenting severity of psoriasis, assessed at the time of initial presentation, in patients of differing ethnoracial groups (white, Asian, Hispanic, African American, and Middle Eastern).
The severity proportions (mild to moderate vs severe to very severe) between different ethnoracial groups were compared using analysis of covariance, adjusting for baseline covariates of age, age of onset, and sex. This revealed that patients from the Asian group had significantly more severe psoriasis than the white group (P \ .0001). Similarly, Hispanics were also found to have more severe psoriasis than whites (P ¼ .016). The African American and Middle Eastern groups were not adequately powered to reveal differences.
This study was a retrospective analysis of data, which has inherent limitations. In addition, the database collection occurs at a single time point, and not continuously over time. Therefore, it is possible that a patient's psoriasis could have worsened in severity after enrollment in the database. Furthermore, the University of California, San Francisco is major academic medical center in an urban area, with referrals possibly leading to a bias toward patients with more severe disease. Our cohort had a predominance of white, Asian, and Hispanic individuals, with less statistical power to detect differences in other ethnoracial groups.
Although many psoriasis studies have focused on the relative differences in prevalence between ethnicities, there is little information available regarding the role of ethnicity in psoriasis severity. Our work examining a psoriasis cohort in an urban academic medical center found that Asians and Hispanics present with more severe psoriasis than whites. Future studies are needed to understand the genetic, environmental, and social determinants of these differences. 
